Skip to main content

CDT Equity Inc.

CDT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001896212

In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.

Other share classesCDTTW

Q4 2024 vs. Q3 2024

How the institutions holding CDT Equity Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CDT: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders3542+7
Shares4.05M8.74M+4.68M (+115.6%)
Value$479.5K$599.0K+$119.5K (+24.9%)

New holders (9)

Institutions that held CDT Equity Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CDT in Q4 2024
InstitutionSharesValue% of portfolio
Jane Street Group, LLC327,928$22.5K0.00%
Two Sigma Securities, LLC167,968$11.5K0.00%
Virtu Financial LLC123,714$8.00K0.00%
Abel Hall, LLC40,023$2.75K0.00%
Two Sigma Investments, LP27,909$1.92K0.00%
BNP Paribas Arbitrage, SA16,427$1.13K0.00%
ProShare Advisors LLC15,966$1.09K0.00%
ADAR1 Capital Management, LLC11,200$7680.00%
SBI Securities Co., Ltd.2,006$1380.00%

Sold out (2)

Institutions that held CDT Equity Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CDT in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
XTX Topco Ltd24,854$2.94K
Nisa Investment Advisors, LLC218$26